Novel costimulators in the immune gene therapy of cancer. by Galea-Lauri, J, Farzaneh, F, Gäken, J

Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells? by GaleaLauri, J, Darling, D, Gaken, J, Farzaneh, F

Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. by Hughes, C, Galea-Lauri, J, Farzaneh, F, Darling, D

Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells by Galea-Lauri, J, Darling, D, Harrison, P, Farzaneh, F

Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions. by Wells, J, Darling, D, Farzaneh, F, Galea-Lauri, J

A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy. by Kuiper, M, GaleaLauri, J, Darling, D, Farzaneh, F, Gaken, J

Comparison of monocyte versus CD34+precursors for the generation of clinical grade dendritic cells for immunotherapy protocols in hepatocellular carcinoma by Daniels, H, Hannoe, J, Galea-Lauri, J, Farzaneh, F, Harrison, P

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendr... by Galea-Lauri, J, Darling, D, Mufti, G, Harrison, P, Farzaneh, F

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination. by Galea-Lauri, J, Wells, J, Darling, D, Harrison, P, Farzaneh, F

Semi-allogeneic dendritic cells can induce antigen-specific T-cell activation, which is not enhanced by concurrent alloreactivity. by Wells, J, Cowled, C, Darling, D, Guinn, B, Farzaneh, F, Noble, A, Galea-Lauri, J

Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre. by Darling, D, Hughes, C, Galea-Lauri, J, Gäken, J, Trayner, I, Kuiper, M, Farzaneh, F

Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. by Galea-Lauri, J, Darling, D, Gan, S, Krivochtchapov, L, Kuiper, M, Gäken, J, Souberbielle, B, Farzaneh, F

IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for A... by Chan, L, Hardwick, N, Darling, D, Galea-Lauri, J, Gäken, J, Devereux, S, Kemeny, M, Mufti, G, Farzaneh, F

IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML by Chan, L, Hardwick, N, Darling, D, Galea-Lauri, J, Gaken, J, Devereux, S, Kemeny, M, Mufti, G, Farzaneh, F

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia. by Chan, L, Hardwick, N, Guinn, B, Darling, D, Gäken, J, Galea-Lauri, J, Ho, A, Mufti, G, Farzaneh, F

Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells. by Chan, L, Nesbeth, D, Mackey, T, Galea-Lauri, J, Gäken, J, Martin, F, Collins, M, Mufti, G, Farzaneh, F, Darling, D

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2. by Hirst, W, Darling, D, Gaken, J, Buggins, A, Barnard, A, GaleaLauri, J, Kuiper, M, Hollignsworth, S, Mufti, G, Farzaneh, F

The human and mouse GATA-6 genes utilize two promoters and two initiation codons. by Brewer, A, Gove, C, Davies, A, McNulty, C, Barrow, D, Koutsourakis, M, Farzaneh, F, Pizzey, J, Bomford, A, Patient, R

High titre vectors for targeted expression of multiple genes by Darling, D, Gaken, J, Nesbeth, D, Chan, L, Hardwick, N, Mackey, T, Galea-Lauri, J, Vyakarnam, A, Mufti, G, Kemeny, M, Farzaneh, F

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells by Gaken, J, Hirst, W, Darling, D, GaleaLauri, J, Buggins, A, Kuiper, M, Souberbielle, B, Towner, P, Hollingsworth, S, Mufti, G, Farzaneh, F